Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company”) announces that the company has closed on all hemp and cannabis assets related for the C&C Cosmeceuticals Corp. subsidiary in escrow as of Friday, April 7th, 2017. The company has issued 3,500,000 shares for the CBD Plant Oils Extraction company; the shares are restricted for a minimum of four months plus a day as they are subject to Canadian securities regulations, exchange and any other required approvals.
The Company can now proceed with the plan of arrangement as approved. The proposed dividend record date for receiving shares in the C&C Cosmeceuticals subsidiary is currently set for Monday April 24th, 2017 which means that the Company would trade ex-dividend on Thursday April 20th, 2017. The share exchange or payout ratio as previously announced will be on a 1:1 basis for all shareholders who have acquired shares in the company before Thursday April 20th, 2017 to receive shares in the C&C Cosmeceuticals subsidiary. A final bulletin will be released confirming all details prior to Thursday April 20th, 2017.
Contact: Ron Ozols, Director
EVITRADE Health Systems Corporation
(formerly Auxellence Health Corporation)
Twitter: @evitradehealth or https://twitter.com/evitradehealth
Email: info@auxellence.com
Website: http://www.auxellence.com
CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp
US OTC Markets: http://www.otcmarkets.com/stock/AXHLF/news
About EVITRADE Health (CSE: EVA, OTCQB: AXHLF)
EVITRADE (formerly Auxellence Health Corp.), was founded in 2013 to provide online “digital healthcare” services for resolving common health problems. The current markets are weight-loss, high blood pressure, high blood glucose and heart arrhythmia.
About C&C Cosmeceuticals Corp. (“C&C” a wholly owned subsidiary of the Company)
C&C was founded in 2011 to develop, manufacture and market nutraceutical and cosmeceutical personal healthcare products and services. It was the predecessor company that acquired Auxellence Health Corporation, which is now named EVITRADE Health Systems Corp. and is a wholly owned subsidiary. On November 15, 2016, the company announced that it signed an MOU to acquire a 50 Hectare Cannabis Farm for C&C and on January 23, 2017 the company that it signed a LOI to acquire a Plant Oils Extraction firm for C&C. On March 3, 2017 at the shareholders meeting, C&C was voted 100% in favour of to be spun off from the parent company and it was announced on March 6, 2017 that C&C was to be spun off on a 1:1 basis. All shareholders holding shares in EVITRADE that have settled in their accounts as of the dividend record date of Monday April 24th, 2017 will receive an equal number of shares in C&C.
Disclaimers – Forward Looking Statements
This news release contains forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and http://www.otcmarkets.com/stock/AXHLF/filings. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/evitrade04102017_0.pdfSource: EVITRADE Health Systems Corp. (CSE:EVA, OTCQB:AXHLF)
To follow EVITRADE Health Systems Corp. on your favorite social media platform or financial websites, please click on the icons below.
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Copyright © 2017 Filing Services Canada Inc.